• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care Resusc. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress sy

tetano

Editor, Senior Moderator
Crit Care Resusc. 2020 Apr 15. [Epub ahead of print]
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.


Ciceri F[SUP]1[/SUP], Beretta L[SUP]2[/SUP], Scandroglio AM[SUP]2[/SUP], Colombo S[SUP]2[/SUP], Landoni G[SUP]3[/SUP], Ruggeri A[SUP]1[/SUP], Peccatori J[SUP]1[/SUP], D'Angelo A[SUP]4[/SUP], De Cobelli F[SUP]2[/SUP], Rovere-Querini P[SUP]2[/SUP], Tresoldi M[SUP]5[/SUP], Dagna L[SUP]2[/SUP], Zangrillo A[SUP]2[/SUP].

Author information




Abstract

We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 (COVID-19). We hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple organ failure and death. Future steps in the understanding of the disease and in the identification of treatments may benefit from this definition and hypothesised sequence of events.



KEYWORDS:

COVID-19


PMID:32294809
 
Back
Top Bottom